A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age

Clinical trial NCT07406347 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07406347
Sponsor: GlaxoSmithKline
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumonia, Bacterial

Start date: 2027-01-25
Primary completion: 2028-10-18
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.